Sexual Functioning After Primary Treatment of Ovarian Cancer
Observational Model: Cohort, Time Perspective: Prospective
To estimate the prevalence of sexual dysfunction, as measured by Female Sexual Functioning Index (FSFI) among women who have completed first-line treatment for ovarian cancer within the last 6 months and currently have no evidence of disease.
conclusion of study
Elizabeth Jewell, MD
Memorial Sloan-Kettering Cancer Center
United States: Institutional Review Board
|Memorial Sloan Kettering Cancer Center||New York, New York 10021|